As a successor to the 2019 Voluntary Scheme for Branded Medicines Access and Pricing is being negotiated, Leela Barham asks where rebates should go in future - that is, if rebates remain at
Daniel Kohlstaedt, managing director and founder of PurpleLeaf Strategy, explores how moving resource planning into the cloud can lead to more simplified, streamlined, and optimised brand p
The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.